$258 Million is the total value of BENDER ROBERT & ASSOCIATES's 54 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COST | COSTCO WHSL CORP NEW | $889,000 | -1.4% | 1,883 | 0.0% | 0.34% | -0.3% | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $864,000 | +19.0% | 68,600 | 0.0% | 0.34% | +20.5% | |
| DE | DEERE & CO | $521,000 | +11.6% | 1,561 | 0.0% | 0.20% | +12.8% | |
| JPM | JPMORGAN CHASE & CO | $432,000 | -7.3% | 4,134 | 0.0% | 0.17% | -6.2% | |
| BA | BOEING CO | $356,000 | -11.4% | 2,940 | 0.0% | 0.14% | -10.4% | |
| URGN | UROGEN PHARMA LTD | $342,000 | +1.5% | 41,131 | 0.0% | 0.13% | +2.3% | |
| CAT | CATERPILLAR INC | $265,000 | -8.3% | 1,617 | 0.0% | 0.10% | -6.4% | |
| DUK | DUKE ENERGY CORP NEW | $244,000 | -13.5% | 2,626 | 0.0% | 0.09% | -13.0% | |
| TROW | PRICE T ROWE GROUP INC | $224,000 | -7.8% | 2,135 | 0.0% | 0.09% | -6.5% | |
| EOLS | EVOLUS INC | $202,000 | -30.6% | 25,070 | 0.0% | 0.08% | -29.7% | |
| BBIG | VINCO VENTURES INC | $74,000 | -32.7% | 80,000 | 0.0% | 0.03% | -31.0% | |
| CLVS | CLOVIS ONCOLOGY INC | $60,000 | -33.3% | 50,000 | 0.0% | 0.02% | -32.4% | |
| GNUS | GENIUS BRANDS INTL INC | $30,000 | -21.1% | 50,000 | 0.0% | 0.01% | -20.0% | |
| JNCE | JOUNCE THERAPEUTICS INC | $23,000 | -23.3% | 10,000 | 0.0% | 0.01% | -18.2% | |
| CMRX | CHIMERIX INC | $20,000 | -9.1% | 10,609 | 0.0% | 0.01% | 0.0% | |
| SMMT | SUMMIT THERAPEUTICS INC | $17,000 | +21.4% | 14,059 | 0.0% | 0.01% | +40.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-10-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 42 | Q3 2023 | 25.0% |
| INTUITIVE SURGICAL INC | 42 | Q3 2023 | 9.6% |
| ILLUMINA INC COM | 42 | Q3 2023 | 8.9% |
| AMAZON COM INC COM | 42 | Q3 2023 | 8.7% |
| LULULEMON ATHLETICA INC | 42 | Q3 2023 | 7.8% |
| MERCADOLIBRE INC COM | 42 | Q3 2023 | 7.8% |
| GILEAD SCIENCES INC C | 42 | Q3 2023 | 8.1% |
| ULTA SALON COSMETCS & FRAG I | 42 | Q3 2023 | 5.6% |
| STARBUCKS CORP COM | 42 | Q3 2023 | 3.1% |
| BRISTOL-MYERS SQUIBB CO | 42 | Q3 2023 | 15.1% |
View BENDER ROBERT & ASSOCIATES's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-23 |
| 13F-HR | 2024-01-31 |
| 13F-HR | 2023-10-16 |
| 13F-HR | 2023-07-14 |
| 13F-HR | 2023-04-21 |
| 13F-HR | 2023-02-02 |
| 13F-HR | 2022-10-27 |
| 13F-HR | 2022-07-19 |
| 13F-HR | 2022-04-14 |
| 13F-HR | 2022-02-07 |
View BENDER ROBERT & ASSOCIATES's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.